Compare Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Risk | Very High | Very High |
Rating | 2.0 | 5.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 1.06 | 1.86 |
NAV | ₹20.69 | ₹38.69 |
Fund Started | 06 Oct 2020 | 25 Jun 2018 |
Fund Size | ₹170.77 Cr | ₹6455.55 Cr |
Exit Load | - | Exit load of 1% if redeemed within 15 days. |
Risk
Very High
Very High
Rating
2.0
5.0
Min SIP Amount
₹100
₹100
Expense Ratio
1.06
1.86
NAV
₹20.69
₹38.69
Fund Started
06 Oct 2020
25 Jun 2018
Fund Size
₹170.77 Cr
₹6455.55 Cr
Exit Load
-
Exit load of 1% if redeemed within 15 days.
1 Year | 9.30% | 1.79% |
3 Year | 19.17% | 26.35% |
5 Year | 13.04% | 16.49% |
1 Year
9.30%
1.79%
3 Year
19.17%
26.35%
5 Year
13.04%
16.49%
Equity | 99.94% | 97.87% |
Cash | -0.10% | 2.13% |
Equity
99.94%
97.87%
Cash
-0.10%
2.13%
Top 10 Holdings |
|
|
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 10.98% |
Eli Lilly And Co | 6.97% |
Cipla Ltd. | 5.69% |
Max Healthcare Institute Ltd. | 5.41% |
Divi's Laboratories Ltd. | 5.08% |
Apollo Hospitals Enterprise Ltd. | 5.05% |
Dr. Reddy's Laboratories Ltd. | 4.59% |
Johnson & Johnson Ltd. | 4.02% |
Lupin Ltd. | 3.53% |
AbbVie Inc | 3.25% |
Sun Pharmaceutical Industries Ltd. | 12.05% |
Cipla Ltd. | 7.90% |
Dr. Reddy's Laboratories Ltd. | 7.82% |
Divi's Laboratories Ltd. | 7.10% |
Mankind Pharma Ltd. | 6.44% |
Lupin Ltd. | 5.78% |
Aurobindo Pharma Ltd. | 5.19% |
Alkem Laboratories Ltd. | 3.66% |
Cohance Lifesciences Ltd. | 3.01% |
Syngene International Ltd. | 2.98% |
Name | - | - |
Start Date | - | - |
Name
-
-
Start Date
-
-
Description | The scheme seeks to invest in stocks comprising of the MSCI India Domestic & World Healthcare 45 Index with the objective to provide investment returns that, before expenses, closely corresponds to the returns equivalent to the index, subject to tracking errors. | The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. |
Launch Date | 06 Oct 2020 | 25 Jun 2018 |
Description
The scheme seeks to invest in stocks comprising of the MSCI India Domestic & World Healthcare 45 Index with the objective to provide investment returns that, before expenses, closely corresponds to the returns equivalent to the index, subject to tracking errors.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
06 Oct 2020
25 Jun 2018